Latest filing published 31 Aug 2016 for Sagent Pharmaceuticals, Inc., €19k.
Michael Ward V is a declared insider of Sagent Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). We count 3 filings, every one of them for a trade on 29 August 2016.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 31 August 2016: a transaction of €19k, in Sagent Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations